Ezaki Glico Co., Ltd. Q2 Financial Results Summary (Japanese GAAP) (Consolidated)

Overview of Earnings

For the second quarter of the fiscal year ending December 2026 (Jan 1, 2025 – Jun 30, 2025), the company posted net sales of 164,495 million yen, operating income of 3,259 million yen, ordinary income of 5,506 million yen, and net income attributable to owners of the parent of 3,744 million yen. Compared with the same period last year, net sales increased, with substantial improvement in ordinary income and net income. Segment-wise, revenue and profit were recorded for each segment including Health & Food, Dairy, Nutrition, and Food Materials, with overseas business contribution noted. The supplemental materials contain detailed segment information and notes to consolidated financial statements.

Outlook & Key Points

The Q2 Financial Results Summary supplemental materials describe the trends in segment revenue and profit, market conditions domestically and overseas, changes in costs, and selling, general and administrative expenses, which are factors influencing future performance. As the overseas business share rises, exchange rate effects, raw material price fluctuations, and the evolution of the new product portfolio are focal points for the impact on results.